Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    8.50 (1.95%)
Bid:
444.50
Ask:
445.00
Spread: 0.50 (0.112%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Director/PDMR Shareholding

26 Aug 2022 18:03

RNS Number : 4429X
Conduit Holdings Limited
26 August 2022
 

 

CHL PDMR RNS Title is hidden

This announcement contains inside information for the purpose of the Market Abuse Regulation (EU) No 596/2014 (which forms part of UK domestic law pursuant to the European Union (Withdrawal) Act 2018, as amended)

 

Conduit Holdings Limited ("Conduit Holdings")

 

Pembroke, Bermuda, 26 August 2022

 

PDMR Notification

 

Conduit Holdings today announces that Trevor Carvey, a person discharging managerial responsibilities in Conduit Holdings ("PDMR"), on 26 August 2022, acquired 25,000 common shares . Trevor's total current shareholding ownership interest now stands at 295,290 common shares.

PDMR Notification of Dealing Form: The notification below, made in accordance with the requirements of the Market Abuse Regulation (EU) 596/2014 (which forms part of UK domestic law pursuant to the European Union (Withdrawal) Act 2018, as amended), provides further details of the transaction.

1

Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA")

a)

Name

Trevor Carvey

2

Reason for the Notification

a)

Position/status

Trevor Carvey - PDMR

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Conduit Holdings Limited

b)

LEI

21380085AE62D1BXSF19

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of

instrument

Common Shares of $0.01 par value

 

Identification code

ISIN BMG243851091

SEDOL BN133N2

b)

Nature of the Transaction

 

 

Acquisition of Shares

c)

Price(s) and volume(s)

 

Price(s)

£3.147; £3.2; £3.185; £3.12; £3.08

Volume(s)

5,000; 5,000; 5,000; 5,000; 5,000

d)

Aggregated information

Aggregated volume

Price

25,000 common shares

 

£78,660 aggregated total

 

£3.146 per common share

e)

Date of the transaction

26 August 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

ENDS

Media contacts

Haggie Partners - David Haggie, Caroline Klein+44 (0) 207 562 4444 ConduitRe@haggie.co.uk

Investor relations and other enquiries:

info@conduitreinsurance.com

Website

Further details of the Conduit Group can be found at its website: https://conduitreinsurance.com/

About Conduit Re

Conduit Re is a pure play global reinsurance business based in Bermuda. Conduit Reinsurance Limited is licensed by the Bermuda Monetary Authority as a Class 4 insurer. A.M. Best has assigned a Financial Strength Rating of A- (Excellent) and a Long-Term Issuer Credit Rating of a- (Excellent) to Conduit Reinsurance Limited. The outlook assigned to these ratings is stable.

Learn more:

Website: https://conduitreinsurance.com/

LinkedIn: https://www.linkedin.com/company/conduit-re

Twitter: https://twitter.com/Conduit_Re

Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a regulated information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in Conduit Holdings.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBRGDIDGDDGDL
Date   Source Headline
8th Dec 20233:45 pmRNSPurchase of Shares by Employee Benefit Trust
7th Dec 20232:22 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20232:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20237:00 amRNSPurchase of Shares by Employee Benefit Trust
5th Dec 20233:46 pmRNSPurchase of Shares by Employee Benefit Trust
1st Dec 20235:28 pmRNSPurchase of Shares by Employee Benefit Trust
30th Nov 20233:28 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20233:51 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20237:00 amRNSHolding(s) in Company
28th Nov 20234:41 pmRNSPurchase of Shares by Employee Benefit Trust
27th Nov 20233:17 pmRNSPurchase of Shares by Employee Benefit Trust
24th Nov 20232:02 pmRNSPurchase of Shares by Employee Benefit Trust
23rd Nov 20234:25 pmRNSPurchase of Shares by Employee Benefit Trust
22nd Nov 20235:06 pmRNSPurchase of Shares by Employee Benefit Trust
17th Nov 20234:20 pmRNSPurchase of Shares by Employee Benefit Trust
8th Nov 20237:00 amRNSDirectorate Change
8th Nov 20237:00 amRNSThird Quarter 2023 Trading Update
26th Oct 20237:00 amRNSNotice of Q3 2023 Trading Update and Webcast
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20233:59 pmRNSDirector/PDMR Shareholding
28th Jul 20237:00 amRNSDirector/PDMR Shareholding
27th Jul 20235:20 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSConduit Interim Results 2023
25th Jul 20237:00 amRNSDirectorate Change
14th Jul 20232:55 pmRNSNotice of H1 2023 Results and Conference Call
22nd Jun 20237:00 amRNSNotice of IFRS 17 Briefing Call
15th Jun 20234:48 pmRNSHolding(s) in Company
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSTransfer of Treasury Shares
19th May 20234:56 pmRNSDirector/PDMR Shareholding
19th May 20237:00 amRNSDirector/PDMR Shareholding
18th May 20237:00 amRNSResults of 2023 AGM
17th May 20237:00 amRNSFirst Quarter 2023 Trading Update
4th May 20234:20 pmRNSNotice of Q1 2023 Trading Update and Webcast
17th Apr 20232:09 pmRNSNotice of AGM
6th Apr 20232:50 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSHolding(s) in Company
7th Mar 20234:28 pmRNSDirector/PDMR Shareholding
6th Mar 202311:25 amRNSPublication of 2022 Annual Report and Accounts
22nd Feb 20237:00 amRNSYear ended 31 December 2022 Preliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.